Abstract
Introduction: A model of fatty liver in postpartum sheep was established to measure blood paraoxonase 1 (PON1) and other biochemical indicators, which were used to predict fatty liver in sheep.
Material and Methods: Sheep were assigned into two experimental groups: a fatty liver group (T, n = 10) and a healthy control group (C, n = 5). PON1 enzyme activity towards paraoxon as a substrate was quantified spectrophotometrically. The results were analysed by t-test and pearson correlation coefficient. Disease was predicted by binary logistic analysis, and diagnostic thresholds were determined by receiver operatingcharacteristic (ROC) analysis.
Results: The activity of serum PON1 in group T was significantly decreased (P < 0.05) when compared with C group, and liver lipid content and the levels of serum BHBA, NEFA, and TG were significantly increased (P < 0.05). Thresholds were lower than 74.0 U/mL for PON1, higher than 0.97 mmol/L for β-hydroxybutyrate, higher than 1.29 mmol/L for non-esterified fatty acids, higher than 0.24 mmol/L for triglycerides, and lower than 71.35 g/L for total protein.
Conclusion: This study verified that PON1, BHBA, NEFA, TG, and TP could be used to predict the risk of fatty liver in sheep.
References
1. Adams L.A., Lindor K.D.: Nonal coholic fatty liver disease. Ann Epidemiol 2007, 17, 863–869.
2. Ahlfors C.E.: Predicting bilirubin neurotoxicity in jaundiced newborns. Curr Opin Pediatr 2010, 22, 129–133.
3. AI-Qudah K.M.: Oxidant and antioxidant profile of hyperketonemic ewes affected by pregnancy toxemia. Vet Clin Path 2011, 40, 60–65.
4. Aviram M., Rosenblat M.: Paraoxonases 1, 2, and 3, oxidative stress, and macrophage foam cell formation during atherosclerosis development. Free Radic Biol Med 2004, 37, 1304–1316.
5. Aviram M., Rosenblat M.: Paraoxonases and cardiovascular diseases: pharmacological and nutritional influences. Curr Opin Lipidol 2005, 16, 393–399.
6. Başoğlu A., Sevinç M., Mahmut O.K., Gökçen M.: Peri and postparturient concentrations of lipid lipoprotein insulin and glucose in normal dairy cows. Turk J Vet Anim Sci 1998, 22, 141–144.
7. Bobe G., Young J.W., Beitz D.C.: Invited review: pathology, etiology, prevention, and treatment of fatty liver in dairy cows. J Dairy Sci 2004, 87, 3105–3124.
8. Bouwstra R., Goselink R., Dobbelaar P., Nielen M., Newbold J., Van Werven T.: The relationship between oxidative damage and vitamin E concentration in blood, milk, and liver tissue from vitamin E supplemented and nonsupplemented periparturient heifers. J Dairy Sci 2008, 91, 977–987.
9. Cal L., Borteiro C., Benech A., Rodas E., Abreu M.N., Cruz, J.C., González Montaña J.R.: Histological changes of the liver and metabolic correlates in ewes with pregnancy toxemia. Arq Bras Med Vet Zootec 2009, 61, 306–312.
10. Christie W.W., Noble R.C., Clegg R.A.: The hydrolysis of very low density lipoproteins and chylomicrons of intestinal origin by lipoprotein lipase in ruminants. Lipids 1986, 21, 252–253.
11. Farid A.S., Honkawa K., Fath E.M., Nonaka N., Horii Y.: Serum paraoxonase-1 as biomarker for improved diagnosis of fatty liver in dairy cows. BMC Vet Res 2013, 9, 1.
12. Gan K.N., Smolen A., Eckerson H.W., La Du B.N.: Purification of human serum paraoxonase/arylesterase. Evidence for one esterase catalyzing both activities. Drug Metab Dispos 1991, 19, 100–106.
13. Gutteridge J.M.: Lipid peroxidation and antioxidants as biomarkers of tissue damage. Clin Chem 1995, 41, 1819–1828.
14. Helman R.G., Adams L.G., Bridges C.H.: The lesions of hepatic fatty cirrhosis in sheep. Vet Pathol 1995, 32, 635–640.
15. Herdt T., Wensing T., Haagsman H.P., Van Golde L.M.G., Breukink H.J.: Hepatic triacylglycerol synthesis during a period of fatty liver development in sheep. J Anim Sci 1988, 66, 1997–2013.
16. Jain S.K., McVie R., Bocchini J.A.: Hyperketonemia (ketosis), oxidative stress and type 1 diabetes. Pathophysiology 2006, 13, 163–170.
17. Mackness M.I., Mackness B., Durrington P.N., Connelly P.W., Hegele R.A.: Paraoxonase: biochemistry, genetics and relationship to plasma lipoproteins. Curr Opin Lipidol 1996, 7, 69–76.
18. Ostrow J.D., Pascolo L., Shapiro S.M., Tiribelli C.: New concepts in bilirubin encephalopathy. Eur J Clin Invest 2003, 33, 988–997.
19. Pessayre D., Mansouri A., Haouzi D., Fromenty B.: Hepatotoxicity due to mitochondrial dysfunction. Cell Biol Toxicol 1999, 15, 367–373.
20. Reichel J., Hänsel W., Hänsch T.W.: Atomic micromanipulation with magnetic surface traps. Phys Rev Lett 1999, 83, 3398.
21. Reid R.L., Hinks N.T.: Studies on the carbohydrate metabolism of sheep. XVIII. The metabolism of glucose, free fatty acids, ketones, and amino acids in late pregnancy and lactation. Crop Pasture Sci 1962, 13, 1112–1123.
22. Sahoo S.S., Patra R.C., Behera P.C., Swarup D.: Oxidative stress indices in the erythrocytes from lactating cows after treatment for subclinical ketosis with antioxidant incorporated in the therapeutic regime. Vet Res Commun 2009, 33, 281–290.
23. Seifi H.A., Gorji-Dooz M., Mohri M., Dalir-Naghadeh B., Farzaneh N.: Variations of energy-related biochemical metabolites during transition period in dairy cows. Com Clin Pathol 2007, 16, 253–258.
24. Soran H., Schofield J.D., Durrington P.N.: Antioxidant properties of HDL. Front Pharmacol 2015, 6, 222–222.
25. Videla L.A.: Energy metabolism, thyroid calorigenesis, and oxidative stress: functional and cytotoxic consequences. Redox Rep 2000, 5, 265–275.
